Allsino Pharmaceutical Co., Ltd. was founded in 2004 by a group of aspiring chemists with extensive experiences in both US and China pharmaceutical industry. In December 2016，Allsino merged with Sinopep but continues to operate independently as a 100% subsidiary company of Sinopep-Allsino Biopharmaceuticals. As premier Contract Development and Manufacturing Organization (CDMO), Allsino offers worldwide clients an intergraded and exclusive customer synthesis service of small molecules from preclinical to commercial stage. Over the years, Allsino Pharmaceutical has demonstrated deep understanding of synthetic chemistry and powerful production capability to meet customers’ complicate needs.